Mersana Therapeutics (MRSN)
(Delayed Data from NSDQ)
$1.45 USD
-0.02 (-1.03%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $1.44 -0.01 (-0.35%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO8/13/24 |
---|---|
Current Quarter | -0.18 |
EPS Last Quarter | -0.16 |
Last EPS Surprise | 11.11% |
ABR | 1.40 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.60 |
Next Year | -0.70 |
EPS (TTM) | -1.14 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 8.20M | 8.53M | 36.95M | 34.75M |
# of Estimates | 3 | 3 | 5 | 4 |
High Estimate | 10.00M | 10.60M | 70.00M | 42.80M |
Low Estimate | 5.00M | 5.00M | 9.25M | 20.00M |
Year ago Sales | 10.65M | 7.70M | 36.85M | 36.95M |
Year over Year Growth Est. | -23.00% | 10.82% | 0.26% | -5.95% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.18 | -0.19 | -0.60 | -0.70 |
# of Estimates | 4 | 3 | 5 | 5 |
Most Recent Consensus | -0.20 | -0.19 | -0.67 | -0.62 |
High Estimate | -0.14 | -0.12 | -0.25 | -0.37 |
Low Estimate | -0.25 | -0.25 | -0.91 | -0.90 |
Year ago EPS | -0.47 | -0.35 | -1.48 | -0.60 |
Year over Year Growth Est. | 61.70% | 45.71% | 59.46% | -16.00% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.18 | -0.19 | -0.60 | -0.70 |
7 Days Ago | -0.18 | -0.19 | -0.60 | -0.70 |
30 Days Ago | -0.18 | -0.19 | -0.60 | -0.70 |
60 Days Ago | -0.18 | -0.19 | -0.60 | -0.70 |
90 Days Ago | -0.18 | -0.19 | -0.60 | -0.70 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.18 | -0.19 | -0.60 | -0.70 |
Zacks Consensus Estimate | -0.18 | -0.19 | -0.60 | -0.70 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.16 | -0.16 | -0.35 | -0.47 | NA |
Estimate | -0.18 | -0.20 | -0.31 | -0.39 | NA |
Difference | 0.02 | 0.04 | -0.04 | -0.08 | -0.02 |
Surprise | 11.11% | 20.00% | -12.90% | -20.51% | -0.58% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more